The real magic of investing comes from buying quality businesses and holding them for decades. With time, compounding takes over, and what begins as a modest investment can grow into a life-changing sum.
Here are three Australian stocks that could reward patient investors over the next 20 years.
Image source: Getty Images
Pro Medicus Ltd (ASX: PME)
Pro Medicus has become one of the ASX's great success stories. It provides advanced medical imaging software to hospitals and healthcare providers across the globe. Its flagship Visage platform allows radiologists to view and manipulate massive imaging files with speed and precision, giving doctors the ability to make faster, more accurate decisions.
Over the past decade, Pro Medicus has delivered extraordinary earnings growth after signing multi-year contracts with leading U.S. health networks. And with healthcare digitisation still in its early stages worldwide, the runway remains long. Especially given the introduction of AI tools and its expansion into other ologies. For investors with a 20-year outlook, Pro Medicus looks like it's only just getting started.
Citi has a buy rating and $350.00 price target on its shares.
Sonic Healthcare Ltd (ASX: SHL)
Sonic Healthcare is another Australian stock with global reach. It is one of the world's largest medical diagnostics companies, providing pathology and radiology services across Australia, Europe, and the United States.
Healthcare demand is remarkably resilient, supported by ageing populations and rising spending on preventative medicine. Sonic's scale and reputation position it as a trusted provider in a critical industry. While its growth may be steadier compared to flashier tech names, it has a history of delivering consistent earnings and dividends. Over a 20-year period, that kind of steady compounding can add up to serious wealth.
Bell Potter has a buy rating and $33.30 price target on its shares.
Temple & Webster Group Ltd (ASX: TPW)
While healthcare provides stability, Temple & Webster offers exposure to one of the fastest-growing areas of the economy: online retail. The Australian stock has built the nation's largest online furniture and homewares store, tapping into the structural shift toward e-commerce.
Temple & Webster has grown rapidly by expanding its product range, building brand recognition, and investing in technology to improve the customer experience. Even after strong gains in recent years, online penetration in Australia's furniture and homewares market remains relatively low, leaving plenty of room for growth. With a nimble business model and strong balance sheet, Temple & Webster could be one of the standout consumer names of the next two decades.
Macquarie has an outperform rating and $31.30 price target on its shares.
